Compliance of patients concerning recommended radiotherapy in breast cancer. Association with recurrence, age, and hormonal therapy;Compliance der Patientinnen in Bezug zur empfohlenen Strahlentherapie beim Mammakarzinom Zusammenhang mit Rezidiv, Alter und Hormontherapie

Strahlentherapie und Onkologie

Volumn 188, Issue 9, 2012, Pages 788-794

  Winzer, K J ^a   Gruber, C ^a   Badakhshi, H ^a   Hinkelbein, M ^b   Denkert, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Gemeinschaftspraxis für Strahlentherapie und Radioonkologie   (Germany)

Author keywords

Breast cancer; Guidelines; Radiation therapy; Recurrence; Treatment outcome

Indexed keywords

ANTINEOPLASTIC AGENT;

AGE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; GERMANY; GUIDELINE ADHERENCE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RADIOTHERAPY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866735086     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0153-9     Document Type: Article

References (23)

1. Athas WF, Adams-Cameron M, Hunt WC et al (2000) Travel distance to radiation therapy and receipt of radiotherapy following breast-conserving surgery. J Natl Cancer Inst 92:269-271
2. Beckmann MW, Brucker C, Hanf V et al (2011) Quality assured health care in certified breast centers and improvement of the prognosis of breast cancer patients. Onkologie 34:362-367
3. Black N (1996) Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215-1218
4. Celaya MO, Rees JR, Gibson JJ et al (2006) Travel distance and season of diagnosis affect treatment choices for women with early-stage breast cancer in a predominantly rural population (United States). Cancer Causes Control 17:851-856
5. Dunst J, Eiermann W, Rauschecker HF et al (2002) Das lokale Rezidiv beim Mammakarzinom. Onkologe 8:867-873
6. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10801 women in 17 randomised trials. Lancet (Early Online Publication)
7. Gruber C (2011) Realisierung der lokoregionären Tumorkonferenzempfehlungen im Versorgungsalltag von Mammakarzinom-Patientinnen des Brustzentrums der Charité Berlin. Medizinische Fakultät der Charité - Universitätsmedizin Berlin 2011
8. Hancke K, Denkinger MD, König J et al (2010) Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Ann Oncol 21:748-753
9. Hébert-Croteau N, Brisson J, Latreille J et al (2004) Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. J Clin Oncol 22:3685-3693
10. Höfken K (2006) Versorgungsforschung- was ist das? Onkologe 12:307-308
11. Hölzel D, Schubert-Fritschle G (2008) Evidenzbasierte Medizin in der Onkologie: spiegelt die Studienlage die klinische Realität wider? Zentralbl Chir 133:15-19
12. Jackisch C, Untch M, Chatsiproios D et al (2006) Das Mammakarzinom: Versorgungslage und Therapiequalität in Deutschland 2004. Zentralbl Gynakol 128:352-361
13. Nattinger AB, Kneusel RT, Hoffmann RG et al (2001) Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 93:1344-1346
14. Nestle-Krämling C, Bölke E, Budach W et al (2011) Hämangiosarkom nach brusterhaltender Therapie beim Mammakarzinom: vier Fallbeispiele mit molekulargenetischer Diagnostik und Literaturübersicht. Strahlenther Onkol 187:656-664
15. Saquib J, Madlensky L, Kealey S et al (2011) Classification of CAM use and its correlates in patients with early-stage breast cancer. Integr Cancer Ther 10:138-147
16. Srokowski TP, Fang S, Duan Z et al (2008) Completion of adjuvant radiation therapy among women with breast cancer. Cancer 113:22-29
17. Truong PT, Bernstein V, Lesperance M et al (2006) Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer. Am J Surg 191:749-755
18. Voordeckers M, Vinh-Hung V, Lamote J et al (2009) Survival benefit with radiation therapy in node-positive breast carcinoma patients. Strahlenther Onkol 185:656-662
19. Waldmann A, Pritzkuleit R, Raspe H et al (2008) S3-Leitlinien-gerechte Versorgung von Patientinnen mit Mammakarzinom. Dtsch Arztebl 105:337-343
20. Wilsdorf-Köhler H, Streller B, Stabenow R (2011) Brustkrebs. Gemeinsames Krebsregister der Länder Berlin, Brandenburg, Mecklenburg-Vorpommern, Sachsen-Anhalt und der Freistaaten Sachsen und Thüringen GKR - Fakten und Wissenswertes Juni 2011, Ausgabe 2
21. Winzer K-J, Bellach J (2010) Wertigkeit der routinemäßig erfassten Nachsorgedaten bei Brustkrebspatientinnen. Zentralbl Chir 153:257-261
22. Wöckel A, Kurzeder C, Geyer V et al (2010) Effects of guideline adherence in primary breast cancer-a 5-year multi-center cohort study of 3976 patients. Breast 19:120-127
23. Wöckel A, Varga D, Atassi Z et al (2010) Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study. Onkologie 33:21-28